Loading...
XNAS
JYNT
Market cap101mUSD
Oct 08, Last price  
7.12USD
1D
-1.11%
1Q
-20.80%
Jan 2017
168.68%
IPO
9.54%
Name

Joint Corp

Chart & performance

D1W1MN
XNAS:JYNT chart
P/E
34.91
P/S
1.85
EPS
0.20
Div yield, %
—
Shrs. gr., 5y
0.74%
Rev. gr., 5y
-1.33%
Revenues
55m
+5.24%
2,784,9425,958,0677,116,66213,835,43120,523,64025,164,00431,789,24948,450,90058,682,97680,011,013101,252,31046,977,47752,163,43054,895,592
Net income
3m
P
-736,295155,635-3,031,220-8,797,321-15,173,872-3,275,233253,0833,323,71213,167,3147,565,047626,705-9,752,197-5,796,8932,907,265
CFO
2m
-80.47%
2,175,937422,217-437,445-6,796,479-10,847,312156,4445,452,2687,521,94911,183,24213,844,0808,209,58414,677,5899,415,0501,838,509

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into two main divisions: corporate-owned clinics and franchised facilities. The firm employs several strategic models for its expansion and day-to-day functioning, which include direct company ownership, various management agreements, licensing its brand to franchisees, and collaborating with regional development partners. As of March 1, 2022, the company maintained approximately 700 active locations throughout the United States. Founded in 2010, The Joint Corp. maintains its primary corporate headquarters in Scottsdale, Arizona.

Key people

Sanjiv Razdan
President, Chief Executive Officer, Director · since 2024
Jake Singleton
Chief Financial Officer · since 2018
Ron Stilwell
Senior Vice President - Operations and Patient Experience · since 2026
Charles Nelles
Chief Technology Officer · since 2022
Debbie Gonzalez
Chief Marketing Officer · since 2025
Steven Knauf
Vice President - Chiropractic and Compliance · since 2022
Lead Independent Director · since 2017
Christopher Grandpre
Director · since 2025
Sandi Karrmann
Director · since 2025
Ronald DaVella
Independent Director · since 2017
Suzanne Decker
Independent Director · since 2017
Independent Director · since 2024
Abraham Hong
Independent Director · since 2018
IPO date
Nov 11, 2014
Employees
359
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT